AngioGenex, Inc.·5

Feb 17, 1:25 PM ET

Murray Martin 5

5 · AngioGenex, Inc. · Filed Feb 17, 2022

Insider Transaction Report

Form 5
Period: 2021-12-31
Murray Martin
DirectorSecretary, Treasurer, CFO
Transactions
  • Award

    Stock Option

    2019-01-15$0.35/sh+75,000$26,25075,000 total
    Exercise: $0.35From: 2019-01-15Exp: 2024-01-15Common Stock (75,000 underlying)
  • Award

    Stock Option

    2021-09-02$0.13/sh+50,000$6,500125,000 total
    Exercise: $0.13From: 2021-09-02Exp: 2026-09-02Common Stock (50,000 underlying)

Documents

1 file
  • 5
    ownership.xmlPrimary